Taiwan's Industrial Technology Research Institute (ITRI) signed a memorandum of understanding (MOU) with German pharmaceutical and life science giant Merck on Monday on cooperation to developed advanced biopharma technologies.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Sports
Taiwan's Chou freezes out Thai opponent to win Arctic Open title
10/13/2025 11:53 AM - Business
U.S. dollar up in Taipei trading
10/13/2025 10:23 AM - Society
Taiwan headline news
10/13/2025 10:10 AM - Business
Taiwan shares open lower
10/13/2025 09:14 AM - Society
High temperatures expected to last until Oct. 19
10/12/2025 07:57 PM